Profile: Onyx Pharmaceuticals, Inc. develops small molecule cancer treatments based on a molecular understanding of cancer. Our products include Nexavar® (sorafenib) tablets, a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis. Our Nexavar® (sorafenib) tablet is an oral, small molecule agent suitable for patients with advanced kidney cancer.